BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36260302)

  • 1. Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial.
    Sadeghipour P; Jenab Y; Moosavi J; Hosseini K; Mohebbi B; Hosseinsabet A; Chatterjee S; Pouraliakbar H; Shirani S; Shishehbor MH; Alizadehasl A; Farrashi M; Rezvani MA; Rafiee F; Jalali A; Rashedi S; Shafe O; Giri J; Monreal M; Jimenez D; Lang I; Maleki M; Goldhaber SZ; Krumholz HM; Piazza G; Bikdeli B
    JAMA Cardiol; 2022 Dec; 7(12):1189-1197. PubMed ID: 36260302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial.
    Barrios D; Durán D; Rodríguez C; Moisés J; Retegui A; Lobo JL; López R; Chasco L; Jara-Palomares L; Muriel A; Otero-Candelera R; Ruiz-Artacho P; Monreal M; Bikdeli B; Jiménez D;
    Chest; 2024 Mar; 165(3):673-681. PubMed ID: 37717936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.
    Kucher N; Boekstegers P; Müller OJ; Kupatt C; Beyer-Westendorf J; Heitzer T; Tebbe U; Horstkotte J; Müller R; Blessing E; Greif M; Lange P; Hoffmann RT; Werth S; Barmeyer A; Härtel D; Grünwald H; Empen K; Baumgartner I
    Circulation; 2014 Jan; 129(4):479-86. PubMed ID: 24226805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.
    Harvey JJ; Huang S; Uberoi R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013083. PubMed ID: 35938605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute pulmonary embolism after catheter-directed thrombolysis with dabigatran vs warfarin: Results of a multicenter randomized RE-SPIRE trial.
    Gostev AA; Valiev E; Zeidlits GA; Shmidt EA; Osipova OS; Cheban AV; Saaya SB; Barbarash OL; Karpenko AA
    J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101848. PubMed ID: 38346475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study.
    Klok FA; Piazza G; Sharp ASP; Ní Ainle F; Jaff MR; Chauhan N; Patel B; Barco S; Goldhaber SZ; Kucher N; Lang IM; Schmidtmann I; Sterling KM; Becker D; Martin N; Rosenfield K; Konstantinides SV
    Am Heart J; 2022 Sep; 251():43-53. PubMed ID: 35588898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Catheter-Directed Therapy Plus Anticoagulation Versus Anticoagulation Alone for Submassive and Massive Pulmonary Embolism.
    Hennemeyer C; Khan A; McGregor H; Moffett C; Woodhead G
    Am J Med; 2019 Feb; 132(2):240-246. PubMed ID: 30367851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism.
    Kroupa J; Buk M; Weichet J; Malikova H; Bartova L; Linkova H; Ionita O; Kozel M; Motovska Z; Kocka V
    EuroIntervention; 2022 Oct; 18(8):e639-e646. PubMed ID: 35620984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE).
    Sterling KM; Goldhaber SZ; Sharp ASP; Kucher N; Jones N; Maholic R; Meneveau N; Zlotnick D; Sayfo S; Konstantinides SV; Piazza G
    Circ Cardiovasc Interv; 2024 Mar; 17(3):e013448. PubMed ID: 38264938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
    Piazza G; Hohlfelder B; Jaff MR; Ouriel K; Engelhardt TC; Sterling KM; Jones NJ; Gurley JC; Bhatheja R; Kennedy RJ; Goswami N; Natarajan K; Rundback J; Sadiq IR; Liu SK; Bhalla N; Raja ML; Weinstock BS; Cynamon J; Elmasri FF; Garcia MJ; Kumar M; Ayerdi J; Soukas P; Kuo W; Liu PY; Goldhaber SZ;
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1382-1392. PubMed ID: 26315743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial.
    Sanchez O; Charles-Nelson A; Ageno W; Barco S; Binder H; Chatellier G; Duerschmied D; Empen K; Ferreira M; Girard P; Huisman MV; Jiménez D; Katsahian S; Kozak M; Lankeit M; Meneveau N; Pruszczyk P; Petris A; Righini M; Rosenkranz S; Schellong S; Stefanovic B; Verhamme P; de Wit K; Vicaut E; Zirlik A; Konstantinides SV; Meyer G;
    Thromb Haemost; 2022 May; 122(5):857-866. PubMed ID: 34560806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-Assisted Catheter-Directed Thrombolysis in High-Risk and Intermediate-High-Risk Pulmonary Embolism: A Meta-Analysis.
    Kaymaz C; Akbal OY; Tanboga IH; Hakgor A; Yilmaz F; Ozturk S; Poci N; Turkday S; Ozdemir N; Konstantinides S
    Curr Vasc Pharmacol; 2018 Jan; 16(2):179-189. PubMed ID: 28393706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis.
    Planer D; Yanko S; Matok I; Paltiel O; Zmiro R; Rotshild V; Amir O; Elbaz-Greener G; Raccah BH
    CMAJ; 2023 Jun; 195(24):E833-E843. PubMed ID: 37336568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study.
    Tu T; Toma C; Tapson VF; Adams C; Jaber WA; Silver M; Khandhar S; Amin R; Weinberg M; Engelhardt T; Hunter M; Holmes D; Hoots G; Hamdalla H; Maholic RL; Lilly SM; Ouriel K; Rosenfield K;
    JACC Cardiovasc Interv; 2019 May; 12(9):859-869. PubMed ID: 31072507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study.
    Gonsalves CF; Gibson CM; Stortecky S; Alvarez RA; Beam DM; Horowitz JM; Silver MJ; Toma C; Rundback JH; Rosenberg SP; Markovitz CD; Tu T; Jaber WA
    Am Heart J; 2023 Dec; 266():128-137. PubMed ID: 37703948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
    Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
    JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
    Matusov Y; Yaqoob M; Karumanchi A; Lipshutz HG; Dohad S; Steinberger J; Lopez A; Singh S; Tapson VF; Friedman O
    Thromb Res; 2023 May; 225():57-62. PubMed ID: 37003150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-assisted catheter-directed thrombolysis versus anticoagulation alone for management of submassive pulmonary embolism.
    Gorgis S; Mawri S; Dabbagh MF; Aurora L; Ali M; Mitchell G; Jacobsen G; Hegab S; Schwartz S; Kelly B; Grafton G; Awdish R; Ismail R; Koenig G
    J Cardiol; 2022 Nov; 80(5):441-448. PubMed ID: 35643741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.